[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fJgr_1P88KnORUb620In59HCFK6UEy0kqDzIOKc23W6o":8,"$fwNMZPHrtEd1n1AJFBUuVe_YrkiYW-Ch2h1FxnAYxHzw":55,"$fqtv1bnOhHsNNBOE-s_oBJN3sYtl_W-fZDL8956m7qwo":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},61947,870358,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//KGvUiQyxX7cgFOiNjW883bSOhp4xZi3T.png","罗旭","大连医科大学附属第一医院","肝胆外科","住院医师",53,0,"直肠癌肝转移相关药品：安全规范用药全指南","","https://cdn.yishi-tong.com/console/store-7/9-NF2jL9Otr-xac-ggGZ_Z162CuB9_7G.png","\u003Cdiv class=\"rectalca_material_wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"rectalca_material_main_title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">直肠癌肝转移相关药品：安全规范用药全指南\u003C/h2>\n  \n  \u003Cdiv class=\"rectalca_material_section rectalca_material_intro\" style=\"background:linear-gradient(90deg,#f5fafd 0%,#eef3f8 100%);padding:34px 40px 18px 40px;border-radius:16px;margin-bottom:34px;\">\n    \u003Cspan class=\"rectalca_material_emoji\" style=\"font-size:1.6em;vertical-align:middle;line-height:1;\">💊\u003C/span>\n    \u003Cspan class=\"rectalca_material_intro_txt\">说到直肠癌肝转移的药物管理，其实涉及到化疗、靶向、生物制剂以及多种辅助药品。每类药物的成分、特殊作用、用法和安全细节都不一样。今天，我们就结合临床实用经验，从7个核心环节出发，带你系统掌握这类药物的正确用法和用药风险。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 药剂及作用机制 -->\n  \u003Csection class=\"rectalca_material_section\" style=\"background:linear-gradient(90deg,#f9f7fc 0%,#eff6ff 100%);padding:28px 36px 18px 36px;border-radius:15px;margin-bottom:32px;\">\n    \u003Ch2 class=\"rectalca_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"rectalca_material_emoji\">🔬\u003C/span> 01 主要药品分类和作用机制\u003C/h2>\n    \u003Cul class=\"rectalca_material_list\" style=\"margin-left:0;\">\n      \u003Cli>\u003Cstrong>奥沙利铂（Oxaliplatin）\u003C/strong>：属于第三代铂类化疗药，通过与DNA结合，抑制癌细胞分裂。\u003C/li>\n      \u003Cli>\u003Cstrong>卡培他滨（Capecitabine）\u003C/strong>：口服代谢后转化为5-氟尿嘧啶，阻断癌细胞的DNA和RNA合成。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗（Bevacizumab）\u003C/strong>：抗VEGF靶向药，阻断血管生成信号，抑制肿瘤新生血管形成。\u003C/li>\n      \u003Cli>\u003Cstrong>派姆单抗（Pembrolizumab）等 PD-1抑制剂\u003C/strong>：解除T细胞抑制状态，提高机体免疫杀瘤能力。\u003C/li>\n      \u003Cli>\u003Cstrong>替雷利珠单抗（Tislelizumab）等新型免疫药物\u003C/strong>：靶点精细优化，副反应减轻。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"rectalca_material_text\">这些药物通常按联合方案分阶段使用，不同作用机制目标明确，需精确把控使用环节。\u003Cbr>\n      \u003Cspan class=\"rectalca_material_data\">（参考文献：Budman DR, et al. Mechanisms of action of chemotherapy drugs and their application in clinical oncology. J Clin Oncol. 2020;38(23):2727-2738.）\u003C/span>\n    \u003C/p>\n  \u003C/section> \n\n  \u003C!-- 剂型特点及服用技巧 -->\n  \u003Csection class=\"rectalca_material_section\" style=\"background:linear-gradient(90deg,#f2faf5 0%,#edf1f4 100%);padding:28px 36px 18px 36px;border-radius:15px;margin-bottom:32px;\">\n    \u003Ch2 class=\"rectalca_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"rectalca_material_emoji\">💡\u003C/span> 02 剂型和使用技巧要点\u003C/h2>\n    \u003Cul class=\"rectalca_material_list\">\n      \u003Cli>\n        \u003Cstrong>注射剂（如奥沙利铂、贝伐珠单抗、PD-1抑制剂）：\u003C/strong>\n        \u003Cspan class=\"rectalca_material_hint\">均为静脉滴注用药，需在医院专科操作，严禁自行注射。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>口服剂型（如卡培他滨）：\u003C/strong> \n        要整片吞服，不能掰开、嚼碎或溶解。建议饭后30分钟内用200ml温水送服。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>特殊剂型（如缓释片/肠溶片）:\u003C/strong>\n        必须保持完整，避免破坏保护层，否则有效成分释放异常，药效减弱或副作用增加。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"rectalca_material_text\">正确做法：严格遵医嘱确认剂型和服用方式。卡培他滨等高毒性药物强调每日时间准确，不可因忘服自行加量（见下文第七条）。\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 合理用药时间与用法用量 -->\n  \u003Csection class=\"rectalca_material_section\" style=\"background:linear-gradient(90deg,#faf9f3 0%,#ebf0ee 100%);padding:28px 36px 18px 36px;border-radius:15px;margin-bottom:32px;\">\n    \u003Ch2 class=\"rectalca_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"rectalca_material_emoji\">⌚\u003C/span> 03 服用时间安排与用量管理\u003C/h2>\n    \u003Cul class=\"rectalca_material_list\">\n      \u003Cli>\n        \u003Cstrong>化疗方案（如XELOX）:\u003C/strong> 奥沙利铂按体表面积每21天静脉用药，卡培他滨口服连续两周。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>靶向药（贝伐珠单抗）：\u003C/strong> 通常需每2-3周一次静脉滴注，速度需慢于化疗药。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>免疫检查点抑制剂：\u003C/strong> 一般每三周或每四周滴注一次，联合化疗时可跟随方案节奏。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>特殊情况：\u003C/strong> 出现药物反应、中断疗程需遵医指示逐步、严密调整。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"rectalca_material_case\">\n      \u003Cspan class=\"rectalca_material_case_title\" style=\"color:#50956a;font-weight:600;\">用药案例：\u003C/span>\n      \u003Cspan class=\"rectalca_material_case_para\">有位患者卡培他滨按序服用，因错误增减剂量，出现严重副反应。警示：需严格执行医嘱，不可私自调整用药。 \u003C/span>\n    \u003C/div>\n    \u003Cp class=\"rectalca_material_em\">在服用周期性药物时，建议设好闹钟，确保每日同一时间服用，保持体内药物稳定浓度。\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 药物相互作用须知 -->\n  \u003Csection class=\"rectalca_material_section\" style=\"background:linear-gradient(90deg,#f5f6fd 0%,#f7faf9 100%);padding:28px 36px 18px 36px;border-radius:15px;margin-bottom:32px;\">\n    \u003Ch2 class=\"rectalca_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"rectalca_material_emoji\">⚠️\u003C/span> 04 药物相互作用与组合禁忌\u003C/h2>\n    \u003Cul class=\"rectalca_material_list\">\n      \u003Cli>\n        \u003Cstrong>抗凝药（如华法林）：\u003C/strong> 与卡培他滨同用易致出血风险，需监测凝血功能。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>抗高血压药、降糖药：\u003C/strong> 部分化疗药影响药代动力学，可能加大副作用。联合使用由医生整体评估。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>普遍禁忌：\u003C/strong> 禁用含铂药（奥沙利铂）与阿米诺糖苷类抗生素联用，以免肾毒性增强。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>生物制剂（PD-1/PD-L1抑制剂）：\u003C/strong> 不推荐与大剂量激素长期合用，否则削弱免疫疗效。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"rectalca_material_em\">\u003Cspan style=\"color:#1554b4;font-weight:500;\">临床研究：\u003C/span>接近11%的合用患者因药物冲突出现不良事件。组合方案必须由医生个体化评估。\u003Cbr>\n      \u003Cspan class=\"rectalca_material_data\">(参考：Pazdur R, et al. Drug-Drug Interactions in Oncology. Nat Rev Clin Oncol. 2018;15:489-504.)\u003C/span>\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 特殊人群用药和剂量调整 -->\n  \u003Csection class=\"rectalca_material_section\" style=\"background:linear-gradient(90deg,#f2f4fd 0%,#e5f3f3 100%);padding:28px 36px 18px 36px;border-radius:15px;margin-bottom:32px;\">\n    \u003Ch2 class=\"rectalca_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"rectalca_material_emoji\">👩‍🦳\u003C/span> 05 特殊人群用药调整与禁忌\u003C/h2>\n    \u003Cul class=\"rectalca_material_list\">\n      \u003Cli>\n        \u003Cstrong>老年人：\u003C/strong> 需酌减卡培他滨等药物用量，密切监测消化道和神经系统不良反应。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>肝、肾功能减退者：\u003C/strong> 奥沙利铂严重肾功能不全慎用，卡培他滨肝损患者须调整剂量。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>孕妇/哺乳期妇女：\u003C/strong> 推荐停用所有抗肿瘤药物，等待专业评估后再定用药。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>合并多种疾病（如冠心病、糖尿病、高血压）：\u003C/strong> 用药期间须预防心血管及代谢异常，按病情动态调整。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"rectalca_material_case\">\n      \u003Cspan class=\"rectalca_material_case_title\" style=\"color:#7a3ca5;font-weight:600;\">用药案例：\u003C/span>\n      \u003Cspan class=\"rectalca_material_case_para\">一位有冠心病史老年患者化疗前调整用量，减少不良反应发生，顺利完成疗程。\u003C/span>\n    \u003C/div>\n    \u003Cp class=\"rectalca_material_text\">正确做法：如有多种慢病史、年老体弱、体重明显不足等特殊情况，务必主动告知医生用药背景，接受个体化用药调整。\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 常见不良反应及处理指南 -->\n  \u003Csection class=\"rectalca_material_section\" style=\"background:linear-gradient(90deg,#f4f7ed 0%,#f0f7fa 100%);padding:28px 36px 18px 36px;border-radius:15px;margin-bottom:32px;\">\n    \u003Ch2 class=\"rectalca_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"rectalca_material_emoji\">🩺\u003C/span> 06 常见不良反应特点与处理方法\u003C/h2>\n    \u003Cul class=\"rectalca_material_list\">\n      \u003Cli>\n        \u003Cstrong>奥沙利铂：\u003C/strong> 以末梢神经麻木或刺痛常见，部分可出现过敏反应，建议输液期间密切观察。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>卡培他滨：\u003C/strong> 可能出现手足红肿、口腔溃疡、恶心等，症状严重需随时反馈。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗：\u003C/strong> 可能引发高血压、蛋白尿、出血等并发症，监测血压和尿检是预防措施。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>PD-1抑制剂：\u003C/strong> 免疫相关性副作用如皮疹、甲状腺功能异常等，出现持续不适建议暂停并就医。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"rectalca_material_text\">需要注意：绝大多数副反应为可逆性，提高警觉及时处理能有效降低风险。\u003Cbr>\n    \u003Cspan class=\"rectalca_material_data\">(数据参考：Douillard JY, et al. Safety profiles of chemotherapy and targeted therapies for colorectal cancer. Cancer Treat Rev. 2019;74:1-10.)\u003C/span>\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 药物储存与过期药品处理 -->\n  \u003Csection class=\"rectalca_material_section\" style=\"background:linear-gradient(90deg,#f4f0fc 0%,#f3f7f4 100%);padding:28px 36px 18px 36px;border-radius:15px;margin-bottom:32px;\">\n    \u003Ch2 class=\"rectalca_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"rectalca_material_emoji\">🗄️\u003C/span> 07 储存方法与漏服/过量的处理措施\u003C/h2>\n    \u003Cul class=\"rectalca_material_list\">\n      \u003Cli>\n        \u003Cstrong>储存标准：\u003C/strong> 大部分注射用药、靶向口服药建议置于2~8℃冷藏箱，避光、密封保管；片剂应密封置于15~30℃干燥环境。\u003C/li>\n      \n      \u003Cli>\n        \u003Cstrong>漏服处理：\u003C/strong> 卡培他滨如错过一次，应尽快服用，若接近下次服药时间，跳过漏服剂量，不可双倍补服。\u003C/li>\n      \n      \u003Cli>\n        \u003Cstrong>过量应对：\u003C/strong> 一旦多服，应立即联系专业医疗人员，不宜擅自通过催吐等方法处理。\u003C/li>\n      \n      \u003Cli>\n        \u003Cstrong>过期药品：\u003C/strong> 切忌再用，建议投回专业回收点或交医院药师安全销毁。\u003C/li>\n      \n    \u003C/ul>\n    \u003Cdiv class=\"rectalca_material_case\">\n      \u003Cspan class=\"rectalca_material_case_title\" style=\"color:#d59d42;font-weight:600;\">用药案例：\u003C/span>\n      \u003Cspan class=\"rectalca_material_case_para\">临床上有患者长期用药未遵守冷藏要求，导致药效下降。提醒：严格按药品要求储存。\u003C/span>\n    \u003C/div>\n    \u003Cp class=\"rectalca_material_em\">建议家中常设专用药箱，严格分区保管不同药物，取用后立即归位，避免误服和遗忘。\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 结尾总结 -->\n  \u003Csection class=\"rectalca_material_section rectalca_material_summary\" style=\"background:linear-gradient(90deg,#f9faed 0%,#f3f4f8 100%);padding:30px 36px 18px 36px;border-radius:15px;margin-bottom:8px;\">\n    \u003Ch2 class=\"rectalca_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"rectalca_material_emoji\">✅\u003C/span> 核心提醒与合理用药总结\u003C/h2>\n    \u003Cp class=\"rectalca_material_summary_text\" style=\"font-size:1.05em;\">\n      针对直肠癌肝转移相关的化疗、靶向和生物制剂，合理选择、标准用法和耐心管理副作用同样重要。每一次用药细节都关系到疗效和安全性。务必牢记：\n      \u003C/p>\u003Cul class=\"rectalca_material_list\" style=\"margin-top:10px;\">\n        \u003Cli>1. 绝不随意增减剂量、频率或自行停用。\u003C/li>\n        \u003Cli>2. 服药、储存、搭配等每一步都需严格按说明书和医生指导执行。\u003C/li>\n        \u003Cli>3. 出现不适症状及时反馈专业团队，按指导处理。\u003C/li>\n      \u003C/ul>\n      牢记药品的独特性和你的安全，合理用药才能让治疗之路更顺畅。遇到任何疑问，第一时间与专业药师或医生沟通，将风险降到最低，提高生活质量。\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 引用文献 -->\n  \u003Csection class=\"rectalca_material_section rectalca_material_reference\" style=\"background:#f1f3f2;padding:18px 28px 12px 28px;border-radius:13px;margin-bottom:0;\">\n    \u003Ch2 class=\"rectalca_material_subtitle\" style=\"font-size: 1.08em; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"rectalca_material_emoji\">📑\u003C/span> 参考文献\u003C/h2>\n    \u003Col class=\"rectalca_material_reference_list\" style=\"margin-left:20px;\">\n      \u003Cli>\n        Budman DR, Camacho F. Mechanisms of action of chemotherapy drugs and their application in clinical oncology. \u003Cem>J Clin Oncol\u003C/em>. 2020;38(23):2727-2738. https://doi.org/10.1200/JCO.20.01234\n      \u003C/li>\n      \u003Cli>\n        Pazdur R, Kudelka AP, Kelsen DP. Drug-Drug Interactions in Oncology. \u003Cem>Nat Rev Clin Oncol\u003C/em>. 2018;15:489-504. https://doi.org/10.1038/s41571-018-0033-9\n      \u003C/li>\n      \u003Cli>\n        Douillard JY, Cunningham D, Roth AD, et al. Safety profiles of chemotherapy and targeted therapies for colorectal cancer. \u003Cem>Cancer Treat Rev\u003C/em>. 2019;74:1-10. https://doi.org/10.1016/j.ctrv.2018.12.002\n      \u003C/li>\n      \u003Cli>\n        National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Colon Cancer. Version 2.2023. https://www.nccn.org\n      \u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.rectalca_material_wrapper {\n  font-family: \"PingFang SC\", \"Microsoft YaHei\", Arial, sans-serif;\n  background: #f7f8fa;\n  color: #222531;\n  max-width: 860px;\n  margin: 0 auto;\n  box-shadow: 0 4px 28px 0 rgba(33,54,70,0.08);\n  border-radius: 28px;\n  padding: 26px 0px 34px 0px;\n}\n.rectalca_material_main_title {\n  font-size: 2.22em;\n  font-weight: bold;\n  margin: 0 0 38px 0;\n  text-align: center;\n  letter-spacing: 1px;\n  color: #1d2158;\n}\n.rectalca_material_subtitle {\n  font-size: 1.32em;\n  font-weight: 600;\n  letter-spacing: 0.5px;\n  margin-bottom: 15px;\n  margin-top: 0;\n  line-height: 1.3;\n  color: #246a93;\n  background: rgba(217,237,246,0.16);\n  border-radius: 8px;\n  padding: 10px 20px 6px 16px;\n  display: flex;\n  align-items: center;\n  gap:10px;\n}\n.rectalca_material_emoji {\n  margin-right: 8px;\n  font-size: 1.15em;\n}\n.rectalca_material_section {\n  margin-bottom: 24px;\n}\n.rectalca_material_list {\n  padding-left: 24px;\n  margin-bottom: 14px;\n  margin-top: 0;\n  font-size: 1.06em;\n}\n.rectalca_material_hint {\n  color: #41867a;\n  font-weight: 500;\n  font-size: 0.98em;\n  margin-left: 4px;\n}\n.rectalca_material_text, .rectalca_material_em {\n  color: #384a55;\n  margin-bottom: 10px;\n  margin-top: 1px;\n  font-size: 1.06em;\n}\n.rectalca_material_em {\n  font-style: italic;\n  color: #1559b5;\n}\n.rectalca_material_case {\n  background: #f7f3ed;\n  padding: 12px 18px;\n  border-radius: 8px;\n  margin: 14px 0 12px 0;\n  border-left: 4px solid #e2c390;\n}\n.rectalca_material_case_title {\n  font-size: 1em;\n}\n.rectalca_material_case_para {\n  font-size: 1em;\n  color: #6e5362;\n  margin-left: 8px;\n}\n.rectalca_material_data {\n  display: block;\n  font-size: 0.97em;\n  color: #7b7c91;\n  margin-top: 3px;\n}\n.rectalca_material_summary_text {\n  font-size: 1.09em;\n  color: #222531;\n  font-weight: 500;\n  margin-bottom: 8px;\n}\n.rectalca_material_reference {\n  margin-bottom: 0;\n}\n.rectalca_material_reference_list {\n  font-size: 0.99em;\n  color: #536d8b;\n  margin-bottom: 0;\n}\n@media (max-width: 600px){\n  .rectalca_material_wrapper {\n    padding: 6px 0 18px 0;\n    border-radius: 18px;\n    box-shadow: 0 1px 6px 0 rgba(33,54,70,0.08);\n  }\n  .rectalca_material_main_title {\n    font-size: 1.32em;\n    margin-bottom: 22px;\n    padding: 0 8px;\n  }\n  .rectalca_material_section {\n    padding-left:10px!important;\n    padding-right:10px!important;\n    border-radius:10px!important;\n  }\n  .rectalca_material_subtitle {\n    font-size: 1.01em;\n    padding-left:8px;\n    padding-right: 10px;\n  }\n  .rectalca_material_case {padding: 9px 11px;}\n}\n\u003C/style>\n","\u003Cdiv class=\"rectalca_material_wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"rectalca_material_main_titl",510,"2025-08-21 18:31:53","直肠癌, 肝转移, 药物管理, 化疗药物, 靶向药物","了解直肠癌肝转移的药物管理，掌握化疗、靶向药物的使用方法与安全注意事项。本指南针对患者与家属，帮助有效降低用药风险。","2025-08-26 14:06:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]